The World’s Best Businesses At A Discount
In today’s Saturday Stock Screen, we’re taking a look at high-quality companies trading at discounts to their historical valuations.
Each week, here at Porter & Co. we apply our brainpower to uncover the most compelling, highest-upside investment ideas. And with this complimentary issue of the Daily Journal, we draw the curtain back to show you how we do it.
An important tool in our analytical toolbox is our stock screens, in which apply a list of criteria – relating to different financial, accounting, and performance parameters – to sift through the 3,000+ publicly traded stocks on U.S. markets. That’s how we are able to identify the tiny fraction of the universe of U.S.-listed stocks that offer the best opportunities for making money.
We often use the results from these screens as a starting point for more in-depth analysis for possible inclusion in The Big Secret On Wall Street portfolio.
In last Wednesday’s Daily Journal, Porter warned investors that it “seems like we’re on the verge of a market panic.” He explained how buying stocks precisely when other investors are panicking, measured by the CBOE Volatility Index (VIX) rising above 30, can create incredible long-term wealth-building opportunities. But even more important than when to buy, is what to buy, as Porter explained:
“What really matters? Understanding which stocks are going to produce far higher than average results is important.”
With the market panic accelerating last week, sending the VIX index to as high as 26, we’re already seeing some attractive bargains beginning to emerge. So this week, we’re using a screening tool that identifies when the world’s best businesses trade at discounted valuations.
For Partner Pass members, we’ll often highlight an opportunity from the screen, or elsewhere, that appears particularly compelling – not as an official recommendation, but as a stock that’s on our radar.Questions about our Saturday Stock Screen?… drop us an email at porterstansberrydirect@gmail.com.
The filtering tool we’re showcasing this week is named “The World’s Best Businesses At Discounted Valuations Screen.”
We created this screen to identify capital efficient business models that not only generate above-average cash flow, but that return a lot of cash to shareholders over time as well. We also added a screening criteria to identify when these businesses trade at discounts to their historic valuations, as detailed below:
- Return on assets (“ROA”) exceeding 15% over the last five years, as a filter for capital efficiency
- Free cash flow (“FCF”) margins exceeding 10% over the last five years, to select for businesses with above-average cash flow generation
- Shareholder returns (including dividends and buybacks) that exceed 10% of the total market capitalization of the business over the last five years
- Annual revenue increasing at more than 4% over the last five years, to select for businesses with steady growth
- Market capitalization over $1 billion to exclude micro-cap, low-liquidity stocks
- Stocks trading at a discount to their 10-year average valuation, defined as the enterprise value (market capitalization plus net debt) to free cash flow (“EV/FCF”) multiple
As of Thursday’s close, this screen produced the following 32 stocks, ranked in order from greatest valuation discount to least:
Highs And Lows
Each week, we also monitor any stocks in the market making new 52-week highs. We do this because any stock on its way to generating 2x, 3x, or 10x returns will spend a lot of time making new 52-week highs along the way. Thus, the new 52-week-high list provides an opportunity to flag these potential high performers before they really break out, with a particular emphasis on lower-profile, less widely-followed stocks that might have otherwise gone unnoticed.
Notable stocks making new 52-week highs last week:
- 3M (MMM)
- Abbott Laboratories (ABT)
- American Healthcare REIT (AHR)
- Antero Midstream (AM)
- Arthur J. Gallagher (AJG)
- AutoZone (AZO)
- Embraer (ERJ)
- Franco-Nevada (FNV)
- Intercontinental Exchange (ICE)
- McKesson (MCK)
- Medtronic (MDT)
- Quest Diagnostics (DGX)
- Republic Services (RSG)
- Rollins (ROL)
- Turning Point Brands (TPB)
- Waste Management (WM)
- Wheaton Precious Metals (WPM)
- XPeng (XPEV)
We also monitor stocks on the new 52-week-low list. In many cases, the names on this list are there for good reason – the market is often correctly pricing in their weak fundamentals. However, once in a while, a great business with excellent long-term prospects finds itself on this list due to a temporary setback. This can create the rare opportunity to buy top-shelf merchandise at bargain-basement prices.
Notable stocks making new 52-week lows last week:
- Owens Corning (OC)
- Alpha Metallurgical Resources (AMR)
- Booz Allen Hamilton (BAH)
- Deckers Outdoor (DECK)
- H.B. Fuller (HBR)
- Hovnanian Enterprises (HOV)
- IDEX (IEX)
- Installed Building Products (IBP)
- Martin Marietta Materials (MLM)
- MGM Resources (MGM)
- NextDoor Holdings (KIND)
Good investing,
Porter Stansberry
Stevenson, MD
P.S. One biotech to rule them all?
Presented by George Gilder
I believe I’ve found the one biotech to rule them all… the next Pfizer.
My research tells me this groundbreaking technology could revolutionize medicine more than antibiotics, X-rays, and anesthesia… combined.
It could help make aging, injury, and disease virtually obsolete.
That’s why it’s my top pick for the $59 billion New You medical market.
Yet don’t take my word for it.
Click here now to see why I call this the “one biotech to rule them all/the next Pfizer.”